Suramin: A novel growth factor antagonist with activity in hormone- refractory metastatic prostate cancer

Journal of Clinical Oncology

Volumn 10, Issue 6, 1992, Pages 881-889

  Myers, C ^a   Cooper, M ^a   Stein, C ^a   LaRocca, R ^a   Walther, M M ^a   Weiss, G ^a   Choyke, P ^a   Dawson, N ^a   Steinberg, S ^a   Uhrich, M M ^a   Cassidy, J ^a   Kohler, D R ^a   Trepel, J ^a   Linehan, W M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; PROSTATE SPECIFIC ANTIGEN; SURAMIN;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE SCINTISCANNING; BRAIN HEMORRHAGE; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; DIAGNOSIS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INFUSION; ENZYME INHIBITION; HORMONAL THERAPY; HUMAN; MALIGNANT TRANSFORMATION; METASTASIS; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0026740863     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1992.10.6.881     Document Type: Article

References (0)